7
Participants
Start Date
May 13, 2025
Primary Completion Date
December 30, 2025
Study Completion Date
June 1, 2026
paclitaxel cationic liposome for injection
Paclitaxel cationic liposome was administered through hepatic arterial catheter infusion, in a gradual increment dose range from 33 mg/m\^2 to 55 mg/m\^2
Oxaliplatin
Oxaliplatin 130 mg/m2 i.v. on D1
Capecitabine
Capecitabine 1000 mg/m2 p.o. Bid on Day 1-14
Bevacizumab
Bevacizumab 7.5 mg/kg i.v. on D1
RECRUITING
The First Affiliated Hospital of Sun Yat-sen University,Lishui Central Hospital, Lishui
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
INDUSTRY